DrugBank_ID,Name,Description,Toxicity,Categories,Patents,Sequence,Interactions,References
DB00001,Lepirudin,Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539..L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609]  Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT).. an immune reaction associated with a high risk of thromboembolic complications.[A3.. L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31.. 2012.[L41574],The acute toxicity of intravenous lepirudin was evaluated in mice (0.1-1000 mg/kg).. rats (1-1000 mg/kg).. and monkeys (1-100 mg/kg).. and toxicity was not detected at the doses investigated.[L41539] The acute toxicity of lepirudin administered subcutaneously was also evaluated in mice (1-1250 mg/kg) and rats (1-500 mg/kg).. and no toxicity was detected.[L41539] One rat (100 mg/kg) died of rapid blood loss after the subcutaneous administration of lepirudin. Reactions to local injections such as hemorrhages.. hematomas and/or nodules were detected in mice and rats given subcutaneous doses of lepirudin equal or higher than 500 mg/kg and 10 mg/kg.. respectively.[L41539] Chronic toxicity was evaluated in rats and monkeys given lepirudin for up to 3 months. Most of the effects observed were due to the antithrombotic action of lepirudin. After 3 months.. hemosiderin deposits in the spleen and moderate sinus histiocytosis in the lymph node were observed in rats. In monkeys.. external and internal hemorrhages and hematomas were detected.[L41539] Lepidurin was reported as not mutagenic.[L41539]Relative overdose may occur in patients with renal impairment.. therefore.. bolus dose and rate of infusion must be reduced in case of known or suspected renal insufficiency.[L41539] Excessively high activated partial thromboplastin time (aPTT) values suggest an overdose and a risk of bleeding. Lepirudin has no known antidote. In case of life-threatening bleeding and if excessive plasma levels of lepirudin are suspected: 1)stop the administration of lepirudin immediately.. 2) determine aPTT and coagulation parameters.. 3) determine hemoglobin.. and prepare for a transfusion.. 4) follow the treatment guidelines for patients with shock.[L41539] Hemofiltration or hemodialysis may be useful in case of overdose.. based in single case reports and animal data.[L41539],Amino Acids.. Peptides.. and Proteins:Anticoagulants:Antithrombin Proteins:Antithrombins:Blood and Blood Forming Organs:Cardiovascular Agents:Enzyme Inhibitors:Fibrin Modulating Agents:Hematologic Agents:Peptides:Protease Inhibitors:Proteins:Serine Protease Inhibitors:Serpins:Thrombin Inhibitors,[5180668:United States:1993-01-19],>DB00001 sequenceLTYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ,[DB06605:Apixaban:Apixaban may increase the anticoagulant activities of Lepirudin.];[DB06695:Dabigatran etexilate:Dabigatran etexilate may increase the anticoagulant activities of Lepirudin.];[DB01254:Dasatinib:The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Lepirudin.];[DB01609:Deferasirox:The risk or severity of gastrointestinal bleeding can be increased when Lepirudin is combined with Deferasirox.];[DB01586:Ursodeoxycholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Ursodeoxycholic acid.];[DB02123:Glycochenodeoxycholic Acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycochenodeoxycholic Acid.];[DB02659:Cholic Acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Cholic Acid.];[DB02691:Glycocholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycocholic acid.];[DB03619:Deoxycholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Deoxycholic acid.];[DB04348:Taurocholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurocholic acid.];[DB05990:Obeticholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Obeticholic acid.];[DB06777:Chenodeoxycholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Chenodeoxycholic acid.];[DB08833:Taurochenodeoxycholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid.];[DB08834:Tauroursodeoxycholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid.];[DB08857:Bamet-UD2:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Bamet-UD2.];[DB11622:Dehydrocholic acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Dehydrocholic acid.];[DB11789:Hyodeoxycholic Acid:The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Hyodeoxycholic Acid.];[DB09075:Edoxaban:The risk or severity of bleeding can be increased when Edoxaban is combined with Lepirudin.];[DB09053:Ibrutinib:The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Lepirudin.];[DB08935:Obinutuzumab:The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Obinutuzumab.];[DB06228:Rivaroxaban:Lepirudin may increase the anticoagulant activities of Rivaroxaban.];[DB06206:Sugammadex:The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Sugammadex.];[DB09070:Tibolone:Tibolone may increase the anticoagulant activities of Lepirudin.];[DB00932:Tipranavir:The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Lepirudin.];[DB00013:Urokinase:Urokinase may increase the anticoagulant activities of Lepirudin.];[DB00163:Vitamin E:Vitamin E may increase the anticoagulant activities of Lepirudin.];[DB09030:Vorapaxar:The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Lepirudin.];[DB01381:Ginkgo biloba:Ginkgo biloba may increase the anticoagulant activities of Lepirudin.];[DB01181:Ifosfamide:The risk or severity of bleeding can be increased when Ifosfamide is combined with Lepirudin.];[DB00468:Quinine:The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinine.];[DB00908:Quinidine:The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.];[DB00675:Tamoxifen:The risk or severity of bleeding can be increased when Tamoxifen is combined with Lepirudin.];[DB00539:Toremifene:The risk or severity of bleeding can be increased when Toremifene is combined with Lepirudin.];[DB00806:Pentoxifylline:The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.];[DB00686:Pentosan polysulfate:Pentosan polysulfate may increase the anticoagulant activities of Lepirudin.];[DB00583:Levocarnitine:The therapeutic efficacy of Lepirudin can be increased when used in combination with Levocarnitine.];[DB00255:Diethylstilbestrol:Diethylstilbestrol may decrease the anticoagulant activities of Lepirudin.];[DB00269:Chlorotrianisene:Chlorotrianisene may decrease the anticoagulant activities of Lepirudin.];[DB00286:Conjugated estrogens:Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.];[DB01357:Mestranol:The risk or severity of adverse effects can be increased when Mestranol is combined with Lepirudin.];[DB04574:Estrone sulfate:Estrone sulfate may decrease the anticoagulant activities of Lepirudin.];[DB04575:Quinestrol:Quinestrol may decrease the anticoagulant activities of Lepirudin.];[DB07931:Hexestrol:Hexestrol may decrease the anticoagulant activities of Lepirudin.];[DB09317:Synthetic Conjugated Estrogens.. A:Synthetic Conjugated Estrogens.. A may decrease the anticoagulant activities of Lepirudin.];[DB09318:Synthetic Conjugated Estrogens.. B:Synthetic Conjugated Estrogens.. B may decrease the anticoagulant activities of Lepirudin.];[DB09369:Polyestradiol phosphate:Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin.];[DB09381:Esterified estrogens:Esterified estrogens may decrease the anticoagulant activities of Lepirudin.];[DB11478:Zeranol:Zeranol may decrease the anticoagulant activities of Lepirudin.];[DB11674:Equol:Equol may decrease the anticoagulant activities of Lepirudin.];[DB13143:Methallenestril:Methallenestril may decrease the anticoagulant activities of Lepirudin.];[DB13386:Epimestrol:Epimestrol may decrease the anticoagulant activities of Lepirudin.];[DB13418:Moxestrol:Moxestrol may decrease the anticoagulant activities of Lepirudin.];[DB13952:Estradiol acetate:Estradiol acetate may decrease the anticoagulant activities of Lepirudin.];[DB13953:Estradiol benzoate:Estradiol benzoate may decrease the anticoagulant activities of Lepirudin.];[DB13954:Estradiol cypionate:Estradiol cypionate may decrease the anticoagulant activities of Lepirudin.];[DB13956:Estradiol valerate:Estradiol valerate may decrease the anticoagulant activities of Lepirudin.];[DB15334:Biochanin A:Biochanin A may decrease the anticoagulant activities of Lepirudin.];[DB15335:Formononetin:Formononetin may decrease the anticoagulant activities of Lepirudin.];[DB04573:Estriol:Estriol may decrease the anticoagulant activities of Lepirudin.];[DB09211:Limaprost:The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin.];[DB00159:Icosapent:The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Lepirudin.];[DB00244:Mesalazine:The risk or severity of bleeding can be increased when Mesalazine is combined with Lepirudin.];[DB00328:Indomethacin:The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Lepirudin.];[DB00461:Nabumetone:The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Lepirudin.];[DB00465:Ketorolac:The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Lepirudin.];[DB00469:Tenoxicam:The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Lepirudin.];[DB00482:Celecoxib:The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Lepirudin.];[DB00500:Tolmetin:The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Lepirudin.];[DB00533:Rofecoxib:The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Lepirudin.];[DB00554:Piroxicam:The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Lepirudin.];[DB00573:Fenoprofen:The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Lepirudin.];[DB00580:Valdecoxib:The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Lepirudin.];[DB00586:Diclofenac:The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Lepirudin.];[DB00605:Sulindac:The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Lepirudin.];[DB00712:Flurbiprofen:The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Lepirudin.];[DB00749:Etodolac:The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Lepirudin.];[DB00784:Mefenamic acid:The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Lepirudin.];[DB00788:Naproxen:The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Lepirudin.];[DB00795:Sulfasalazine:The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Lepirudin.];[DB00812:Phenylbutazone:The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Lepirudin.];[DB00814:Meloxicam:The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Lepirudin.];[DB00821:Carprofen:The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Lepirudin.];[DB00861:Diflunisal:The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Lepirudin.];[DB00936:Salicylic acid:The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Lepirudin.];[DB00939:Meclofenamic acid:The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Lepirudin.];[DB00991:Oxaprozin:The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Lepirudin.];[DB01009:Ketoprofen:The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Lepirudin.];[DB01014:Balsalazide:The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Lepirudin.];[DB01250:Olsalazine:The risk or severity of bleeding can be increased when Olsalazine is combined with Lepirudin.];[DB01283:Lumiracoxib:The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Lepirudin.];[DB01397:Magnesium salicylate:The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Lepirudin.];[DB01399:Salsalate:The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Lepirudin.];[DB01401:Choline magnesium trisalicylate:The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Lepirudin.];[DB01419:Antrafenine:The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Lepirudin.];[DB01424:Aminophenazone:The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Lepirudin.];[DB01435:Antipyrine:The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Lepirudin.];[DB01600:Tiaprofenic acid:The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Lepirudin.];[DB01628:Etoricoxib:The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Lepirudin.];[DB02224:Taxifolin:The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Lepirudin.];[DB03585:Oxyphenbutazone:The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Lepirudin.];[DB04725:Licofelone:The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Lepirudin.];[DB04812:Benoxaprofen:The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Lepirudin.];[DB04828:Zomepirac:The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Lepirudin.];[DB05095:Cimicoxib:The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Lepirudin.];[DB06725:Lornoxicam:The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Lepirudin.];[DB06736:Aceclofenac:The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Lepirudin.];[DB06737:Zaltoprofen:The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Lepirudin.];[DB07402:Azapropazone:The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Lepirudin.];[DB08439:Parecoxib:The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Lepirudin.];[DB08797:Salicylamide:The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Lepirudin.];[DB08940:Kebuzone:The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Lepirudin.];[DB08942:Isoxicam:The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Lepirudin.];[DB08951:Indoprofen:The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Lepirudin.];[DB08955:Ibuproxam:The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Lepirudin.];[DB08976:Floctafenine:The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Lepirudin.];[DB08981:Fenbufen:The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin.];[DB08984:Etofenamate:The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Lepirudin.];[DB08991:Epirizole:The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Lepirudin.];[DB09084:Benzydamine:The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Lepirudin.];[DB09214:Dexketoprofen:The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Lepirudin.];[DB09215:Droxicam:The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Lepirudin.];[DB09216:Tolfenamic acid:The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Lepirudin.];[DB09217:Firocoxib:The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Lepirudin.];[DB09218:Clonixin:The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Lepirudin.];[DB09285:Morniflumate:The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Lepirudin.];[DB09288:Propacetamol:The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Lepirudin.];[DB09295:Talniflumate:The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Lepirudin.];[DB11455:Robenacoxib:The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Lepirudin.];[DB11466:Tepoxalin:The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Lepirudin.];[DB11518:Flunixin:The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Lepirudin.];[DB12399:Polmacoxib:The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Lepirudin.];[DB12610:Ebselen:The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Lepirudin.];[DB13001:Tinoridine:The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Lepirudin.];[DB13167:Alclofenac:The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Lepirudin.];[DB13217:Fentiazac:The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Lepirudin.];[DB13232:Suxibuzone:The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Lepirudin.];[DB13286:Bumadizone:The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Lepirudin.];[DB13314:Alminoprofen:The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Lepirudin.];[DB13371:Difenpiramide:The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Lepirudin.];[DB13407:Nifenazone:The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Lepirudin.];[DB13432:Lonazolac:The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Lepirudin.];[DB13481:Tenidap:The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Lepirudin.];[DB13524:Propyphenazone:The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Lepirudin.];[DB13527:Proglumetacin:The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Lepirudin.];[DB13538:Guacetisal:The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Lepirudin.];[DB13544:Ethenzamide:The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Lepirudin.];[DB13612:Carbaspirin calcium:The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Lepirudin.];[DB13629:Mofebutazone:The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Lepirudin.];[DB13649:Proquazone:The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Lepirudin.];[DB13657:Benorilate:The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Lepirudin.];[DB13722:Pirprofen:The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Lepirudin.];[DB13860:Imidazole salicylate:The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Lepirudin.];[DB14059:SC-236:The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Lepirudin.];[DB14060:NS-398:The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Lepirudin.];[DB14938:Flurbiprofen axetil:The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Lepirudin.];[DB09212:Loxoprofen:The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Lepirudin.];[DB04552:Niflumic acid:The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Lepirudin.];[DB04865:Omacetaxine mepesuccinate:The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate.];[DB11133:Omega-3 fatty acids:Omega-3 fatty acids may increase the anticoagulant activities of Lepirudin.];[DB00081:Tositumomab:The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab.];[DB00048:Collagenase clostridium histolyticum:The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.];[DB00389:Carbimazole:Carbimazole may increase the anticoagulant activities of Lepirudin.];[DB00550:Propylthiouracil:Propylthiouracil may increase the anticoagulant activities of Lepirudin.];[DB00763:Methimazole:Methimazole may increase the anticoagulant activities of Lepirudin.];[DB03374:3..5-Diiodotyrosine:3..5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin.];[DB06715:Potassium Iodide:Potassium Iodide may increase the anticoagulant activities of Lepirudin.];[DB07637:Dibromotyrosine:Dibromotyrosine may increase the anticoagulant activities of Lepirudin.];[DB09418:Potassium perchlorate:Potassium perchlorate may increase the anticoagulant activities of Lepirudin.];[DB13644:Methylthiouracil:Methylthiouracil may increase the anticoagulant activities of Lepirudin.];[DB13804:Benzylthiouracil:Benzylthiouracil may increase the anticoagulant activities of Lepirudin.];[DB04066:p-Coumaric acid:The therapeutic efficacy of Lepirudin can be decreased when used in combination with p-Coumaric acid.];[DB04682:Octylphenoxy polyethoxyethanol:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.];[DB05830:Trestolone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trestolone.];[DB06266:Lonidamine:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Lonidamine.];[DB08867:Ulipristal:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ulipristal.];[DB11507:Cloprostenol:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cloprostenol.];[DB12025:Triptolide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triptolide.];[DB13044:Gossypol:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gossypol.];[DB00294:Etonogestrel:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etonogestrel.];[DB00378:Dydrogesterone:Dydrogesterone may decrease the anticoagulant activities of Lepirudin.];[DB00396:Progesterone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Progesterone.];[DB01431:Allylestrenol:Allylestrenol may decrease the anticoagulant activities of Lepirudin.];[DB06713:Norelgestromin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Norelgestromin.];[DB06789:Hydroxyprogesterone caproate:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroxyprogesterone caproate.];[DB09124:Medrogestone:Medrogestone may decrease the anticoagulant activities of Lepirudin.];[DB11372:Altrenogest:Altrenogest may decrease the anticoagulant activities of Lepirudin.];[DB11636:Nomegestrol:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Nomegestrol.];[DB13230:Gestonorone:Gestonorone may decrease the anticoagulant activities of Lepirudin.];[DB13533:Methylestrenolone:Methylestrenolone may decrease the anticoagulant activities of Lepirudin.];[DB13602:Promegestone:Promegestone may decrease the anticoagulant activities of Lepirudin.];[DB13866:Etynodiol:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etynodiol.];[DB14570:Hydroxyprogesterone:Hydroxyprogesterone may decrease the anticoagulant activities of Lepirudin.];[DB14679:Quingestanol acetate:Quingestanol acetate may decrease the anticoagulant activities of Lepirudin.];[DB00233:Aminosalicylic acid:The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin.];[DB01294:Bismuth subsalicylate:The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin.];[DB06251:Dersalazine:The risk or severity of bleeding can be increased when Dersalazine is combined with Lepirudin.];[DB06807:Phenyl aminosalicylate:The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Lepirudin.];[DB09543:Methyl salicylate:The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin.];[DB11079:Trolamine salicylate:The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Lepirudin.];[DB13509:Aloxiprin:The risk or severity of bleeding can be increased when Aloxiprin is combined with Lepirudin.];[DB14006:Choline salicylate:The risk or severity of bleeding can be increased when Choline salicylate is combined with Lepirudin.];[DB14026:Thiosalicylic acid:The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Lepirudin.];[DB00054:Abciximab:The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.];[DB00063:Eptifibatide:The risk or severity of bleeding can be increased when Eptifibatide is combined with Lepirudin.];[DB00208:Ticlopidine:The risk or severity of bleeding can be increased when Ticlopidine is combined with Lepirudin.];[DB00261:Anagrelide:The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin.];[DB00758:Clopidogrel:The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.];[DB00775:Tirofiban:The risk or severity of bleeding can be increased when Tirofiban is combined with Lepirudin.];[DB00975:Dipyridamole:The risk or severity of bleeding can be increased when Dipyridamole is combined with Lepirudin.];[DB01088:Iloprost:Iloprost may increase the anticoagulant activities of Lepirudin.];[DB01138:Sulfinpyrazone:The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lepirudin.];[DB01166:Cilostazol:The risk or severity of bleeding can be increased when Cilostazol is combined with Lepirudin.];[DB01207:Ridogrel:The risk or severity of bleeding can be increased when Ridogrel is combined with Lepirudin.];[DB01240:Epoprostenol:The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin.];[DB02709:Resveratrol:The risk or severity of bleeding can be increased when Resveratrol is combined with Lepirudin.];[DB04743:Nimesulide:The risk or severity of bleeding can be increased when Nimesulide is combined with Lepirudin.];[DB04905:Tesmilifene:The risk or severity of bleeding can be increased when Tesmilifene is combined with Lepirudin.];[DB04932:Defibrotide:The risk or severity of bleeding can be increased when Defibrotide is combined with Lepirudin.];[DB05229:Beraprost:The risk or severity of bleeding can be increased when Beraprost is combined with Lepirudin.];[DB05266:Ibudilast:The risk or severity of bleeding can be increased when Ibudilast is combined with Lepirudin.];[DB05767:Andrographolide:The risk or severity of bleeding can be increased when Andrographolide is combined with Lepirudin.];[DB06081:Caplacizumab:The risk or severity of bleeding can be increased when Caplacizumab is combined with Lepirudin.];[DB06209:Prasugrel:The risk or severity of bleeding can be increased when Prasugrel is combined with Lepirudin.];[DB06441:Cangrelor:The risk or severity of bleeding can be increased when Cangrelor is combined with Lepirudin.];[DB07615:Tranilast:The risk or severity of bleeding can be increased when Tranilast is combined with Lepirudin.];[DB08814:Triflusal:The risk or severity of bleeding can be increased when Triflusal is combined with Lepirudin.];[DB08816:Ticagrelor:The risk or severity of bleeding can be increased when Ticagrelor is combined with Lepirudin.];[DB08887:Icosapent ethyl:The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Lepirudin.];[DB09283:Trapidil:The risk or severity of bleeding can be increased when Trapidil is combined with Lepirudin.];[DB12092:Naftopidil:The risk or severity of bleeding can be increased when Naftopidil is combined with Lepirudin.];[DB12163:Sarpogrelate:The risk or severity of bleeding can be increased when Sarpogrelate is combined with Lepirudin.];[DB12321:Ifetroban:The risk or severity of bleeding can be increased when Ifetroban is combined with Lepirudin.];[DB12445:Nitroaspirin:The risk or severity of bleeding can be increased when Nitroaspirin is combined with Lepirudin.];[DB12545:Indobufen:The risk or severity of bleeding can be increased when Indobufen is combined with Lepirudin.];[DB12749:Butylphthalide:The risk or severity of bleeding can be increased when Butylphthalide is combined with Lepirudin.];[DB12771:Hydroxytyrosol:The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Lepirudin.];[DB13036:Ramatroban:The risk or severity of bleeding can be increased when Ramatroban is combined with Lepirudin.];[DB13327:Picotamide:The risk or severity of bleeding can be increased when Picotamide is combined with Lepirudin.];[DB13367:Cloricromen:The risk or severity of bleeding can be increased when Cloricromen is combined with Lepirudin.];[DB13400:Linsidomine:The risk or severity of bleeding can be increased when Linsidomine is combined with Lepirudin.];[DB13510:Buflomedil:The risk or severity of bleeding can be increased when Buflomedil is combined with Lepirudin.];[DB13929:Relcovaptan:The risk or severity of bleeding can be increased when Relcovaptan is combined with Lepirudin.];[DB15786:Maritime pine extract:The risk or severity of bleeding can be increased when Maritime pine extract is combined with Lepirudin.];[DB00374:Treprostinil:The risk or severity of bleeding can be increased when Treprostinil is combined with Lepirudin.];[DB03404:Hemin:Hemin may increase the anticoagulant activities of Lepirudin.];[DB13783:Acemetacin:The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Acemetacin.];[DB00624:Testosterone:Testosterone may increase the anticoagulant activities of Lepirudin.];[DB01420:Testosterone propionate:Testosterone propionate may increase the anticoagulant activities of Lepirudin.];[DB01481:1-Testosterone:1-Testosterone may increase the anticoagulant activities of Lepirudin.];[DB01485:4-Hydroxytestosterone:4-Hydroxytestosterone may increase the anticoagulant activities of Lepirudin.];[DB01510:Dehydrochloromethyltestosterone:Dehydrochloromethyltestosterone may increase the anticoagulant activities of Lepirudin.];[DB01541:Boldenone:Boldenone may increase the anticoagulant activities of Lepirudin.];[DB01543:18-methyl-19-nortestosterone:18-methyl-19-nortestosterone may increase the anticoagulant activities of Lepirudin.];[DB01564:Calusterone:Calusterone may increase the anticoagulant activities of Lepirudin.];[DB01569:Formebolone:Formebolone may increase the anticoagulant activities of Lepirudin.];[DB01572:Methyl-1-testosterone:Methyl-1-testosterone may increase the anticoagulant activities of Lepirudin.];[DB07447:5beta-dihydrotestosterone:5beta-dihydrotestosterone may increase the anticoagulant activities of Lepirudin.];[DB08619:Testosterone succinate:Testosterone succinate may increase the anticoagulant activities of Lepirudin.];[DB11429:Mibolerone:Mibolerone may increase the anticoagulant activities of Lepirudin.];[DB13943:Testosterone cypionate:Testosterone cypionate may increase the anticoagulant activities of Lepirudin.];[DB13944:Testosterone enanthate:Testosterone enanthate may increase the anticoagulant activities of Lepirudin.];[DB13946:Testosterone undecanoate:Testosterone undecanoate may increase the anticoagulant activities of Lepirudin.];[DB13947:Testosterone enantate benzilic acid hydrazone:Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Lepirudin.];[DB13951:Stanolone acetate:Stanolone acetate may increase the anticoagulant activities of Lepirudin.];[DB13958:Trestolone acetate:Trestolone acetate may increase the anticoagulant activities of Lepirudin.];[DB14093:(1..2..6..7-3H)Testosterone:(1..2..6..7-3H)Testosterone may increase the anticoagulant activities of Lepirudin.];[DB14655:Drostanolone propionate:Drostanolone propionate may increase the anticoagulant activities of Lepirudin.];[DB02901:Stanolone:Stanolone may increase the anticoagulant activities of Lepirudin.];[DB11051:Azficel-T:The risk or severity of adverse effects can be increased when Lepirudin is combined with Azficel-T.];[DB09568:Omega-3-carboxylic acids:The therapeutic efficacy of Lepirudin can be increased when used in combination with Omega-3-carboxylic acids.];[DB00025:Antihemophilic factor.. human recombinant:The therapeutic efficacy of Antihemophilic factor.. human recombinant can be decreased when used in combination with Lepirudin.];[DB00036:Coagulation factor VIIa Recombinant Human:The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.];[DB00100:Coagulation Factor IX (Recombinant):The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Lepirudin.];[DB01373:Calcium:The therapeutic efficacy of Calcium can be decreased when used in combination with Lepirudin.];[DB01783:Pantothenic acid:The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Lepirudin.];[DB01942:Formic acid:The therapeutic efficacy of Formic acid can be decreased when used in combination with Lepirudin.];[DB02261:Platelet Activating Factor:The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Lepirudin.];[DB09109:Turoctocog alfa:The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Lepirudin.];[DB09222:Fibrinogen human:The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Lepirudin.];[DB09310:Catridecacog:The therapeutic efficacy of Catridecacog can be decreased when used in combination with Lepirudin.];[DB09329:Antihemophilic factor (recombinant).. PEGylated:The therapeutic efficacy of Antihemophilic factor (recombinant).. PEGylated can be decreased when used in combination with Lepirudin.];[DB11311:Prothrombin:The therapeutic efficacy of Prothrombin can be decreased when used in combination with Lepirudin.];[DB11330:Factor IX Complex (Human):The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Lepirudin.];[DB11606:Susoctocog alfa:The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Lepirudin.];[DB11608:Eftrenonacog alfa:The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Lepirudin.];[DB11668:Rusalatide acetate:The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Lepirudin.];[DB12409:Vatreptacog alfa:The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Lepirudin.];[DB12909:Factor XIII (human):The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Lepirudin.];[DB13133:Von Willebrand factor human:The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Lepirudin.];[DB13148:Coagulation factor X human:The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Lepirudin.];[DB13150:Coagulation factor VII human:The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Lepirudin.];[DB13151:Anti-inhibitor coagulant complex:The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Lepirudin.];[DB13152:Coagulation Factor IX Human:The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Lepirudin.];[DB13192:Antihemophilic factor human:The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Lepirudin.];[DB13197:Kallidinogenase:The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin.];[DB13201:Trenonacog alfa:The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Lepirudin.];[DB13884:Albutrepenonacog alfa:The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Lepirudin.];[DB13923:Emicizumab:The therapeutic efficacy of Emicizumab can be decreased when used in combination with Lepirudin.];[DB13933:Nonacog beta pegol:The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Lepirudin.];[DB13999:Moroctocog alfa:The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Lepirudin.];[DB14473:Beroctocog alfa:The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Lepirudin.];[DB14562:Andexanet alfa:The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Lepirudin.];[DB14577:Calcium cation:The therapeutic efficacy of Calcium cation can be decreased when used in combination with Lepirudin.];[DB14700:Damoctocog alfa pegol:The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Lepirudin.];[DB14738:Turoctocog alfa pegol:The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Lepirudin.];[DB00176:Fluvoxamine:The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Lepirudin.];[DB00215:Citalopram:The risk or severity of bleeding can be increased when Lepirudin is combined with Citalopram.];[DB00472:Fluoxetine:The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Lepirudin.];[DB00715:Paroxetine:The risk or severity of hemorrhage can be increased when Paroxetine is combined with Lepirudin.];[DB01149:Nefazodone:The risk or severity of hemorrhage can be increased when Nefazodone is combined with Lepirudin.];[DB04832:Zimelidine:The risk or severity of hemorrhage can be increased when Zimelidine is combined with Lepirudin.];[DB04884:Dapoxetine:The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Lepirudin.];[DB06731:Seproxetine:The risk or severity of hemorrhage can be increased when Seproxetine is combined with Lepirudin.];[DB08953:Indalpine:The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin.];[DB12693:Ritanserin:The risk or severity of hemorrhage can be increased when Ritanserin is combined with Lepirudin.];[DB13233:Alaproclate:The risk or severity of hemorrhage can be increased when Alaproclate is combined with Lepirudin.];[DB00476:Duloxetine:The risk or severity of hemorrhage can be increased when Duloxetine is combined with Lepirudin.];[DB01105:Sibutramine:The risk or severity of hemorrhage can be increased when Sibutramine is combined with Lepirudin.];[DB04896:Milnacipran:The risk or severity of hemorrhage can be increased when Milnacipran is combined with Lepirudin.];[DB06700:Desvenlafaxine:The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Lepirudin.];[DB08918:Levomilnacipran:The risk or severity of bleeding can be increased when Lepirudin is combined with Levomilnacipran.];[DB00285:Venlafaxine:The risk or severity of bleeding can be increased when Lepirudin is combined with Venlafaxine.];[DB00601:Linezolid:The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.];[DB00614:Furazolidone:The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Lepirudin.];[DB00721:Procaine:The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.];[DB00752:Tranylcypromine:The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Lepirudin.];[DB00780:Phenelzine:The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Lepirudin.];[DB00805:Minaprine:The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Lepirudin.];[DB01037:Selegiline:The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Lepirudin.];[DB01168:Procarbazine:The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Lepirudin.];[DB01171:Moclobemide:The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Lepirudin.];[DB01247:Isocarboxazid:The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Lepirudin.];[DB01367:Rasagiline:The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Lepirudin.];[DB01626:Pargyline:The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Lepirudin.];[DB04017:Clorgiline:The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Lepirudin.];[DB04818:Iproniazid:The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Lepirudin.];[DB04820:Nialamide:The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Lepirudin.];[DB06654:Safinamide:The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Lepirudin.];[DB08550:7..8-Dichloro-1..2..3..4-tetrahydroisoquinoline:The risk or severity of bleeding and hemorrhage can be increased when 7..8-Dichloro-1..2..3..4-tetrahydroisoquinoline is combined with Lepirudin.];[DB09241:Methylene blue:The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Lepirudin.];[DB09243:Hydracarbazine:The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Lepirudin.];[DB09244:Pirlindole:The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Lepirudin.];[DB09245:Toloxatone:The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Lepirudin.];[DB09246:Benmoxin:The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Lepirudin.];[DB09248:Mebanazine:The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Lepirudin.];[DB09249:Octamoxin:The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Lepirudin.];[DB09250:Pheniprazine:The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Lepirudin.];[DB09251:Phenoxypropazine:The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Lepirudin.];[DB09252:Pivhydrazine:The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Lepirudin.];[DB09253:Safrazine:The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Lepirudin.];[DB09254:Caroxazone:The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Lepirudin.];[DB13875:Harmaline:The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Lepirudin.];[DB13876:Brofaromine:The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Lepirudin.];[DB00006:Bivalirudin:The risk or severity of bleeding can be increased when Lepirudin is combined with Bivalirudin.];[DB00266:Dicoumarol:The risk or severity of bleeding can be increased when Dicoumarol is combined with Lepirudin.];[DB00278:Argatroban:The risk or severity of bleeding can be increased when Lepirudin is combined with Argatroban.];[DB00407:Ardeparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Ardeparin.];[DB00498:Phenindione:The risk or severity of bleeding can be increased when Lepirudin is combined with Phenindione.];[DB00569:Fondaparinux:The risk or severity of bleeding can be increased when Lepirudin is combined with Fondaparinux.];[DB00682:Warfarin:The risk or severity of bleeding can be increased when Warfarin is combined with Lepirudin.];[DB00946:Phenprocoumon:The risk or severity of bleeding can be increased when Phenprocoumon is combined with Lepirudin.];[DB00974:Edetic acid:The risk or severity of bleeding can be increased when Lepirudin is combined with Edetic acid.];[DB01109:Heparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Heparin.];[DB01225:Enoxaparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Enoxaparin.];[DB01418:Acenocoumarol:The risk or severity of bleeding can be increased when Acenocoumarol is combined with Lepirudin.];[DB04898:Ximelagatran:The risk or severity of bleeding can be increased when Lepirudin is combined with Ximelagatran.];[DB05099:Ancrod:The risk or severity of bleeding can be increased when Ancrod is combined with Lepirudin.];[DB06271:Sulodexide:The risk or severity of bleeding can be increased when Sulodexide is combined with Lepirudin.];[DB06406:Idraparinux:The risk or severity of bleeding can be increased when Lepirudin is combined with Idraparinux.];[DB06635:Otamixaban:The risk or severity of bleeding can be increased when Lepirudin is combined with Otamixaban.];[DB06754:Danaparoid:The risk or severity of bleeding can be increased when Lepirudin is combined with Danaparoid.];[DB06779:Dalteparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Dalteparin.];[DB07767:Ferulic acid:The risk or severity of bleeding can be increased when Lepirudin is combined with Ferulic acid.];[DB08794:Ethyl biscoumacetate:The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Lepirudin.];[DB08813:Nadroparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Nadroparin.];[DB09255:Dextran:The risk or severity of bleeding can be increased when Lepirudin is combined with Dextran.];[DB11095:Desirudin:The risk or severity of bleeding can be increased when Lepirudin is combined with Desirudin.];[DB11268:Protocatechualdehyde:The risk or severity of bleeding can be increased when Lepirudin is combined with Protocatechualdehyde.];[DB11312:Protein C:The risk or severity of bleeding can be increased when Protein C is combined with Lepirudin.];[DB11598:Antithrombin III human:The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin III human.];[DB11984:Letaxaban:The risk or severity of bleeding can be increased when Lepirudin is combined with Letaxaban.];[DB12289:Darexaban:The risk or severity of bleeding can be increased when Lepirudin is combined with Darexaban.];[DB12598:Nafamostat:The risk or severity of bleeding can be increased when Lepirudin is combined with Nafamostat.];[DB12831:Gabexate:The risk or severity of bleeding can be increased when Lepirudin is combined with Gabexate.];[DB13124:Troxerutin:The risk or severity of bleeding can be increased when Lepirudin is combined with Troxerutin.];[DB13136:Fluindione:The risk or severity of bleeding can be increased when Lepirudin is combined with Fluindione.];[DB13149:Protein S human:The therapeutic efficacy of Protein S human can be decreased when used in combination with Lepirudin.];[DB13616:Melagatran:The risk or severity of bleeding can be increased when Lepirudin is combined with Melagatran.];[DB09154:Sodium citrate:The risk or severity of bleeding can be increased when Lepirudin is combined with Sodium citrate.];[DB00031:Tenecteplase:The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.];[DB00055:Drotrecogin alfa:The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Lepirudin.];[DB06822:Tinzaparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Tinzaparin.];[DB13199:Brinase:The risk or severity of bleeding can be increased when Brinase is combined with Lepirudin.];[DB13646:Saruplase:The risk or severity of bleeding can be increased when Saruplase is combined with Lepirudin.];[DB00086:Streptokinase:The risk or severity of bleeding can be increased when Streptokinase is combined with Lepirudin.];[DB04925:Desmoteplase:The risk or severity of bleeding can be increased when Desmoteplase is combined with Lepirudin.];[DB06543:Astaxanthin:The risk or severity of bleeding can be increased when Astaxanthin is combined with Lepirudin.];[DB08994:Ditazole:The risk or severity of bleeding can be increased when Lepirudin is combined with Ditazole.];[DB09258:Bemiparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Bemiparin.];[DB09260:Parnaparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Parnaparin.];[DB13275:Clorindione:The risk or severity of bleeding can be increased when Lepirudin is combined with Clorindione.];[DB13347:Diphenadione:The risk or severity of bleeding can be increased when Lepirudin is combined with Diphenadione.];[DB13451:Tioclomarol:The risk or severity of bleeding can be increased when Lepirudin is combined with Tioclomarol.];[DB00009:Alteplase:The risk or severity of bleeding can be increased when Alteplase is combined with Lepirudin.];[DB00015:Reteplase:The risk or severity of bleeding can be increased when Reteplase is combined with Lepirudin.];[DB00029:Anistreplase:The risk or severity of bleeding can be increased when Anistreplase is combined with Lepirudin.];[DB14094:Tocopherylquinone:The risk or severity of bleeding can be increased when Lepirudin is combined with Tocopherylquinone.];[DB06679:Amediplase:The risk or severity of bleeding can be increased when Amediplase is combined with Lepirudin.];[DB03410:4-hydroxycoumarin:The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Lepirudin.];[DB08496:(R)-warfarin:The risk or severity of bleeding can be increased when Lepirudin is combined with (R)-warfarin.];[DB14055:(S)-Warfarin:The risk or severity of bleeding can be increased when Lepirudin is combined with (S)-Warfarin.];[DB12364:Betrixaban:The risk or severity of bleeding can be increased when Lepirudin is combined with Betrixaban.];[DB11166:Antithrombin Alfa:The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin Alfa.];[DB04665:Coumarin:The risk or severity of bleeding can be increased when Lepirudin is combined with Coumarin.];[DB14726:Dabigatran:The risk or severity of bleeding can be increased when Lepirudin is combined with Dabigatran.];[DB06294:Semuloparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Semuloparin.];[DB12726:Monteplase:The risk or severity of bleeding can be increased when Monteplase is combined with Lepirudin.];[DB09259:Reviparin:The risk or severity of bleeding can be increased when Lepirudin is combined with Reviparin.];[DB15880:Dermatan sulfate:The risk or severity of bleeding can be increased when Lepirudin is combined with Dermatan sulfate.];[DB05361:SR-123781A:The risk or severity of bleeding can be increased when Lepirudin is combined with SR-123781A.];[DB00203:Sildenafil:The risk or severity of hemorrhage can be increased when Lepirudin is combined with Sildenafil.];[DB00008:Peginterferon alfa-2a:The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.];[DB00011:Interferon alfa-n1:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.];[DB00018:Interferon alfa-n3:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.];[DB00022:Peginterferon alfa-2b:The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.];[DB00033:Interferon gamma-1b:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.];[DB00034:Interferon alfa-2a:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a.];[DB00041:Aldesleukin:The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.];[DB00056:Gemtuzumab ozogamicin:The risk or severity of bleeding can be increased when Lepirudin is combined with Gemtuzumab ozogamicin.];[DB00068:Interferon beta-1b:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon beta-1b.];[DB00069:Interferon alfacon-1:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfacon-1.];[DB00073:Rituximab:The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab.];[DB00078:Ibritumomab tiuxetan:The risk or severity of bleeding can be increased when Lepirudin is combined with Ibritumomab tiuxetan.];[DB00087:Alemtuzumab:The risk or severity of bleeding can be increased when Lepirudin is combined with Alemtuzumab.];[DB00105:Interferon alfa-2b:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2b.];[DB00120:Phenylalanine:The risk or severity of bleeding can be increased when Lepirudin is combined with Phenylalanine.];[DB00188:Bortezomib:The risk or severity of bleeding can be increased when Lepirudin is combined with Bortezomib.];[DB00242:Cladribine:The risk or severity of bleeding can be increased when Lepirudin is combined with Cladribine.];[DB00262:Carmustine:The risk or severity of bleeding can be increased when Lepirudin is combined with Carmustine.];[DB00276:Amsacrine:The risk or severity of bleeding can be increased when Lepirudin is combined with Amsacrine.];[DB00291:Chlorambucil:The risk or severity of bleeding can be increased when Lepirudin is combined with Chlorambucil.];[DB00293:Raltitrexed:The risk or severity of bleeding can be increased when Lepirudin is combined with Raltitrexed.];[DB00305:Mitomycin:The risk or severity of bleeding can be increased when Lepirudin is combined with Mitomycin.];[DB00307:Bexarotene:The risk or severity of bleeding can be increased when Lepirudin is combined with Bexarotene.];[DB00309:Vindesine:The risk or severity of bleeding can be increased when Lepirudin is combined with Vindesine.];[DB00322:Floxuridine:The risk or severity of bleeding can be increased when Lepirudin is combined with Floxuridine.];[DB00352:Tioguanine:The risk or severity of bleeding can be increased when Lepirudin is combined with Tioguanine.];[DB00361:Vinorelbine:The risk or severity of bleeding can be increased when Lepirudin is combined with Vinorelbine.];[DB00380:Dexrazoxane:The risk or severity of bleeding can be increased when Lepirudin is combined with Dexrazoxane.];[DB00398:Sorafenib:The risk or severity of bleeding can be increased when Lepirudin is combined with Sorafenib.];[DB00428:Streptozocin:The risk or severity of bleeding can be increased when Lepirudin is combined with Streptozocin.];[DB00441:Gemcitabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Gemcitabine.];[DB00444:Teniposide:The risk or severity of bleeding can be increased when Lepirudin is combined with Teniposide.];[DB00445:Epirubicin:The risk or severity of bleeding can be increased when Lepirudin is combined with Epirubicin.];[DB00446:Chloramphenicol:The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.];[DB00480:Lenalidomide:The risk or severity of bleeding can be increased when Lepirudin is combined with Lenalidomide.];[DB00488:Altretamine:The risk or severity of bleeding can be increased when Lepirudin is combined with Altretamine.];[DB00495:Zidovudine:The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.];[DB00515:Cisplatin:The risk or severity of bleeding can be increased when Lepirudin is combined with Cisplatin.];[DB00526:Oxaliplatin:The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Lepirudin.];[DB00531:Cyclophosphamide:The risk or severity of bleeding can be increased when Lepirudin is combined with Cyclophosphamide.];[DB00544:Fluorouracil:The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.];[DB00552:Pentostatin:The risk or severity of bleeding can be increased when Lepirudin is combined with Pentostatin.];[DB00563:Methotrexate:The risk or severity of bleeding can be increased when Lepirudin is combined with Methotrexate.];[DB00564:Carbamazepine:The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.];[DB00570:Vinblastine:The risk or severity of bleeding can be increased when Lepirudin is combined with Vinblastine.];[DB00619:Imatinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Imatinib.];[DB00631:Clofarabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.];[DB00642:Pemetrexed:The risk or severity of bleeding can be increased when Lepirudin is combined with Pemetrexed.];[DB00694:Daunorubicin:The risk or severity of bleeding can be increased when Lepirudin is combined with Daunorubicin.];[DB00762:Irinotecan:The risk or severity of bleeding can be increased when Lepirudin is combined with Irinotecan.];[DB00773:Etoposide:The risk or severity of bleeding can be increased when Lepirudin is combined with Etoposide.];[DB00851:Dacarbazine:The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.];[DB00853:Temozolomide:The risk or severity of bleeding can be increased when Lepirudin is combined with Temozolomide.];[DB00859:Penicillamine:The risk or severity of bleeding can be increased when Lepirudin is combined with Penicillamine.];[DB00864:Tacrolimus:The risk or severity of bleeding can be increased when Lepirudin is combined with Tacrolimus.];[DB00877:Sirolimus:The risk or severity of bleeding can be increased when Lepirudin is combined with Sirolimus.];[DB00888:Mechlorethamine:The risk or severity of bleeding can be increased when Lepirudin is combined with Mechlorethamine.];[DB00928:Azacitidine:The risk or severity of bleeding can be increased when Lepirudin is combined with Azacitidine.];[DB00958:Carboplatin:The risk or severity of bleeding can be increased when Lepirudin is combined with Carboplatin.];[DB00970:Dactinomycin:The risk or severity of bleeding can be increased when Lepirudin is combined with Dactinomycin.];[DB00987:Cytarabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Cytarabine.];[DB00997:Doxorubicin:The risk or severity of bleeding can be increased when Lepirudin is combined with Doxorubicin.];[DB01005:Hydroxyurea:The risk or severity of bleeding can be increased when Lepirudin is combined with Hydroxyurea.];[DB01008:Busulfan:The risk or severity of bleeding can be increased when Lepirudin is combined with Busulfan.];[DB01030:Topotecan:The risk or severity of bleeding can be increased when Lepirudin is combined with Topotecan.];[DB01033:Mercaptopurine:The risk or severity of bleeding can be increased when Lepirudin is combined with Mercaptopurine.];[DB01041:Thalidomide:The risk or severity of bleeding can be increased when Lepirudin is combined with Thalidomide.];[DB01042:Melphalan:The risk or severity of bleeding can be increased when Lepirudin is combined with Melphalan.];[DB01073:Fludarabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Fludarabine.];[DB01099:Flucytosine:The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine.];[DB01101:Capecitabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.];[DB01169:Arsenic trioxide:The risk or severity of bleeding can be increased when Lepirudin is combined with Arsenic trioxide.];[DB01177:Idarubicin:The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.];[DB01204:Mitoxantrone:The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone.];[DB01206:Lomustine:The risk or severity of bleeding can be increased when Lepirudin is combined with Lomustine.];[DB01229:Paclitaxel:The risk or severity of bleeding can be increased when Lepirudin is combined with Paclitaxel.];[DB01248:Docetaxel:The risk or severity of bleeding can be increased when Lepirudin is combined with Docetaxel.];[DB01262:Decitabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Decitabine.];[DB01280:Nelarabine:The risk or severity of bleeding can be increased when Lepirudin is combined with Nelarabine.];[DB01590:Everolimus:The risk or severity of bleeding can be increased when Lepirudin is combined with Everolimus.];[DB02546:Vorinostat:The risk or severity of bleeding can be increased when Lepirudin is combined with Vorinostat.];[DB04572:Thiotepa:The risk or severity of bleeding can be increased when Lepirudin is combined with Thiotepa.];[DB04845:Ixabepilone:The risk or severity of bleeding can be increased when Lepirudin is combined with Ixabepilone.];[DB04868:Nilotinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Nilotinib.];[DB05015:Belinostat:The risk or severity of bleeding can be increased when Lepirudin is combined with Belinostat.];[DB05109:Trabectedin:The risk or severity of bleeding can be increased when Lepirudin is combined with Trabectedin.];[DB05258:Interferon alfa:The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa.];[DB05472:Human interferon omega-1:The risk or severity of bleeding can be increased when Lepirudin is combined with Human interferon omega-1.];[DB05773:Trastuzumab emtansine:The risk or severity of bleeding can be increased when Lepirudin is combined with Trastuzumab emtansine.];[DB06287:Temsirolimus:The risk or severity of bleeding can be increased when Lepirudin is combined with Temsirolimus.];[DB06616:Bosutinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Bosutinib.];[DB06769:Bendamustine:The risk or severity of bleeding can be increased when Lepirudin is combined with Bendamustine.];[DB06772:Cabazitaxel:The risk or severity of bleeding can be increased when Lepirudin is combined with Cabazitaxel.];[DB08871:Eribulin:The risk or severity of bleeding can be increased when Lepirudin is combined with Eribulin.];[DB08877:Ruxolitinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Ruxolitinib.];[DB08889:Carfilzomib:The risk or severity of bleeding can be increased when Lepirudin is combined with Carfilzomib.];[DB08895:Tofacitinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Tofacitinib.];[DB08901:Ponatinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Ponatinib.];[DB08910:Pomalidomide:The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide.];[DB09042:Tedizolid phosphate:The risk or severity of bleeding can be increased when Lepirudin is combined with Tedizolid phosphate.];[DB09052:Blinatumomab:The risk or severity of bleeding can be increased when Lepirudin is combined with Blinatumomab.];[DB09073:Palbociclib:The risk or severity of bleeding can be increased when Lepirudin is combined with Palbociclib.];[DB09074:Olaparib:The risk or severity of bleeding can be increased when Lepirudin is combined with Olaparib.];[DB09077:Dinutuximab:The risk or severity of bleeding can be increased when Lepirudin is combined with Dinutuximab.];[DB09122:Peginterferon beta-1a:The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon beta-1a.];[DB12814:Cepeginterferon alfa-2B:The risk or severity of bleeding can be increased when Lepirudin is combined with Cepeginterferon alfa-2B.];[DB00229:Cefotiam:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotiam.];[DB00267:Cefmenoxime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmenoxime.];[DB00274:Cefmetazole:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmetazole.];[DB00430:Cefpiramide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpiramide.];[DB00438:Ceftazidime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftazidime.];[DB00447:Loracarbef:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Loracarbef.];[DB00456:Cefalotin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefalotin.];[DB00493:Cefotaxime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotaxime.];[DB00535:Cefdinir:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefdinir.];[DB00567:Cephalexin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.];[DB00671:Cefixime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.];[DB00689:Cephaloglycin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephaloglycin.];[DB00833:Cefaclor:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaclor.];[DB00923:Ceforanide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceforanide.];[DB01066:Cefditoren:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefditoren.];[DB01112:Cefuroxime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefuroxime.];[DB01139:Cefapirin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefapirin.];[DB01140:Cefadroxil:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefadroxil.];[DB01150:Cefprozil:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefprozil.];[DB01212:Ceftriaxone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftriaxone.];[DB01326:Cefamandole:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole.];[DB01327:Cefazolin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazolin.];[DB01328:Cefonicid:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefonicid.];[DB01329:Cefoperazone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoperazone.];[DB01330:Cefotetan:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.];[DB01331:Cefoxitin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoxitin.];[DB01332:Ceftizoxime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftizoxime.];[DB01333:Cefradine:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefradine.];[DB01413:Cefepime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefepime.];[DB01414:Cefacetrile:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefacetrile.];[DB01415:Ceftibuten:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftibuten.];[DB01416:Cefpodoxime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpodoxime.];[DB04570:Latamoxef:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Latamoxef.];[DB04918:Ceftobiprole:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole.];[DB06590:Ceftaroline fosamil:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftaroline fosamil.];[DB09008:Cefaloridine:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaloridine.];[DB09050:Ceftolozane:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftolozane.];[DB09062:Cefminox:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefminox.];[DB11367:Cefroxadine:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefroxadine.];[DB11935:Flomoxef:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Flomoxef.];[DB13266:Cefatrizine:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefatrizine.];[DB13461:Cefcapene:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefcapene.];[DB13470:Cefodizime:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefodizime.];[DB13499:Cefsulodin:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefsulodin.];[DB13504:Cefetamet:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefetamet.];[DB13638:Cefbuperazone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefbuperazone.];[DB13667:Cefozopran:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefozopran.];[DB13682:Cefpirome:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpirome.];[DB13778:Cefazedone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazedone.];[DB13821:Ceftezole:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftezole.];[DB14725:Cefamandole nafate:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole nafate.];[DB00254:Doxycycline:The risk or severity of bleeding can be increased when Doxycycline is combined with Lepirudin.];[DB00207:Azithromycin:The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.];[DB09539:Omega-3-acid ethyl esters:The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Lepirudin.];[DB00945:Acetylsalicylic acid:Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.];[DB01606:Tazobactam:The risk or severity of bleeding can be increased when Tazobactam is combined with Lepirudin.];[DB00199:Erythromycin:The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin.];[DB00656:Trazodone:The risk or severity of bleeding can be increased when Trazodone is combined with Lepirudin.];[DB00620:Triamcinolone:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triamcinolone.];[DB09079:Nintedanib:The risk or severity of bleeding can be increased when Nintedanib is combined with Lepirudin.];[DB01175:Escitalopram:The risk or severity of bleeding can be increased when Escitalopram is combined with Lepirudin.];[DB01104:Sertraline:The risk or severity of bleeding can be increased when Sertraline is combined with Lepirudin.];[DB00232:Methyclothiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methyclothiazide.];[DB00436:Bendroflumethiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Bendroflumethiazide.];[DB00562:Benzthiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Benzthiazide.];[DB00606:Cyclothiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclothiazide.];[DB00774:Hydroflumethiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroflumethiazide.];[DB00880:Chlorothiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Chlorothiazide.];[DB00999:Hydrochlorothiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydrochlorothiazide.];[DB01021:Trichlormethiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trichlormethiazide.];[DB01324:Polythiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Polythiazide.];[DB13430:Mebutizide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mebutizide.];[DB13532:Cyclopenthiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclopenthiazide.];[DB15861:Buthiazide:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Buthiazide.];[DB00783:Estradiol:The risk or severity of adverse effects can be increased when Estradiol is combined with Lepirudin.];[DB00977:Ethinylestradiol:The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Lepirudin.];[DB00834:Mifepristone:The risk or severity of adverse effects can be increased when Mifepristone is combined with Lepirudin.];[DB13310:Ormeloxifene:The risk or severity of adverse effects can be increased when Ormeloxifene is combined with Lepirudin.];[DB00304:Desogestrel:The risk or severity of adverse effects can be increased when Desogestrel is combined with Lepirudin.];[DB00351:Megestrol acetate:The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Lepirudin.];[DB00367:Levonorgestrel:The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Lepirudin.];[DB00603:Medroxyprogesterone acetate:The risk or severity of adverse effects can be increased when Medroxyprogesterone acetate is combined with Lepirudin.];[DB00717:Norethisterone:The risk or severity of adverse effects can be increased when Norethisterone is combined with Lepirudin.];[DB00823:Ethynodiol diacetate:The risk or severity of adverse effects can be increased when Ethynodiol diacetate is combined with Lepirudin.];[DB00957:Norgestimate:The risk or severity of adverse effects can be increased when Norgestimate is combined with Lepirudin.];[DB01395:Drospirenone:The risk or severity of adverse effects can be increased when Drospirenone is combined with Lepirudin.];[DB04839:Cyproterone acetate:The risk or severity of adverse effects can be increased when Cyproterone acetate is combined with Lepirudin.];[DB06730:Gestodene:The risk or severity of adverse effects can be increased when Gestodene is combined with Lepirudin.];[DB09123:Dienogest:The risk or severity of adverse effects can be increased when Dienogest is combined with Lepirudin.];[DB09371:Norethynodrel:The risk or severity of adverse effects can be increased when Norethynodrel is combined with Lepirudin.];[DB09389:Norgestrel:The risk or severity of adverse effects can be increased when Norgestrel is combined with Lepirudin.];[DB11619:Gestrinone:The risk or severity of adverse effects can be increased when Gestrinone is combined with Lepirudin.];[DB12474:Lynestrenol:The risk or severity of adverse effects can be increased when Lynestrenol is combined with Lepirudin.];[DB13528:Chlormadinone:The risk or severity of adverse effects can be increased when Chlormadinone is combined with Lepirudin.];[DB13563:Norgestrienone:The risk or severity of adverse effects can be increased when Norgestrienone is combined with Lepirudin.];[DB13685:Quingestanol:The risk or severity of adverse effects can be increased when Quingestanol is combined with Lepirudin.];[DB13857:Demegestone:The risk or severity of adverse effects can be increased when Demegestone is combined with Lepirudin.];[DB13981:Nomegestrol acetate:The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Lepirudin.];[DB14678:Norethindrone enanthate:The risk or severity of adverse effects can be increased when Norethindrone enanthate is combined with Lepirudin.];[DB15775:Algestone acetophenide:Algestone acetophenide may decrease the anticoagulant activities of Lepirudin.];[DB12235:Estetrol:The risk or severity of adverse effects can be increased when Estetrol is combined with Lepirudin.];[DB11201:Menthyl salicylate:The risk or severity of bleeding and hemorrhage can be increased when Menthyl salicylate is combined with Lepirudin.];[DB11323:Glycol salicylate:The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Lepirudin.];[DB15119:Ropeginterferon alfa-2b:The risk or severity of bleeding can be increased when Lepirudin is combined with Ropeginterferon alfa-2b.];[DB15575:Padeliporfin:The risk or severity of bleeding can be increased when Lepirudin is combined with Padeliporfin.];[DB16007:Rurioctocog alfa pegol:The therapeutic efficacy of Rurioctocog alfa pegol can be decreased when used in combination with Lepirudin.];[DB14733:Ceftobiprole medocaril:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole medocaril.];[DB01051:Novobiocin:The risk or severity of bleeding can be increased when Novobiocin is combined with Lepirudin.];[DB03966:Clorobiocin:The risk or severity of bleeding can be increased when Clorobiocin is combined with Lepirudin.];[DB04571:Trioxsalen:The risk or severity of bleeding can be increased when Trioxsalen is combined with Lepirudin.];[DB04886:Calanolide A:The risk or severity of bleeding can be increased when Calanolide A is combined with Lepirudin.];[DB07118:Hymecromone:The risk or severity of bleeding can be increased when Hymecromone is combined with Lepirudin.];[DB11390:Coumaphos:The risk or severity of bleeding can be increased when Coumaphos is combined with Lepirudin.];[DB11419:Haloxon:The risk or severity of bleeding can be increased when Haloxon is combined with Lepirudin.];[DB12216:Bergapten:The risk or severity of bleeding can be increased when Bergapten is combined with Lepirudin.];[DB12823:Tecarfarin:The risk or severity of bleeding can be increased when Tecarfarin is combined with Lepirudin.];[DB13155:Esculin:The risk or severity of bleeding can be increased when Esculin is combined with Lepirudin.];[DB13177:4-methylumbelliferyl beta-D-glucoside:The risk or severity of bleeding can be increased when 4-methylumbelliferyl beta-D-glucoside is combined with Lepirudin.];[DB13279:Carbocromen:The risk or severity of bleeding can be increased when Carbocromen is combined with Lepirudin.];[DB13912:Coumermycin A1:The risk or severity of bleeding can be increased when Coumermycin A1 is combined with Lepirudin.];[DB09422:Soybean oil:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Soybean oil.];[DB09567:Olive oil:The therapeutic efficacy of Lepirudin can be decreased when used in combination with Olive oil.];[DB15434:Mosunetuzumab:The risk or severity of bleeding can be increased when Lepirudin is combined with Mosunetuzumab.];[DB17472:Pirtobrutinib:The risk or severity of bleeding can be increased when Lepirudin is combined with Pirtobrutinib.];[DB14713:Inotersen:The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Lepirudin.],[article:A1:16244762:Smythe MA.. Stephens JL.. Koerber JM.. Mattson JC: A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost. 2005 Oct;11(4):371-4.];[article:A2:16690967:Tardy B.. Lecompte T.. Boelhen F.. Tardy-Poncet B.. Elalamy I.. Morange P.. Gruel Y.. Wolf M.. Francois D.. Racadot E.. Camarasa P.. Blouch MT.. Nguyen F.. Doubine S.. Dutrillaux F.. Alhenc-Gelas M.. Martin-Toutain I.. Bauters A.. Ffrench P.. de Maistre E.. Grunebaum L.. Mouton C.. Huisse MG.. Gouault-Heilmann M.. Lucke V: Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood. 2006 Sep 1;108(5):1492-6. Epub 2006 May 11.];[article:A3:16241940:Lubenow N.. Eichler P.. Lietz T.. Greinacher A: Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1.. HAT-2.. and HAT-3. J Thromb Haemost. 2005 Nov;3(11):2428-36.];[article:A246609:19707378:Petros S: Lepirudin in the management of patients with heparin-induced thrombocytopenia. Biologics. 2008 Sep;2(3):481-90. doi: 10.2147/btt.s3415.];[article:A246624:25294122:Chapin JC.. Hajjar KA: Fibrinolysis and the control of blood coagulation. Blood Rev. 2015 Jan;29(1):17-24. doi: 10.1016/j.blre.2014.09.003. Epub 2014 Sep 16.];[link:L48:Google books:http://books.google.com/books?id=iadLoXoQkWEC&pg=PA440];[link:L41539:Health Canada Approved Drug Products: Refludan (lepirudin) lyophilized powder for intravenous injection:https://pdf.hres.ca/dpd_pm/00004023.PDF];[link:L41544:FDA Clinical Pharmacology and Biopharmaceutics Review: Refludan (lepirudin) lyophilized powder for intravenous injection:https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20807_Refludan_biopharmr.pdf];[link:L41569:EMA Summary of Product Characteristics: Refludan (lepirudin) powder for intravenous injection or infusion:https://www.ema.europa.eu/en/documents/product-information/refludan-epar-product-information_en.pdf];[link:L41574:Bayer HealthCare: Discontinuation of Refludan [lepirudin (rDNA) for injection]:https://www.hrsa.gov/sites/default/files/opa/programrequirements/manufacturerletters/2012/refludan05312012.pdf]
DB01744,Camphor,Camphor is a bicyclic monoterpene ketone found widely in plants.. especially _Cinnamomum camphora_. It is used topically as a skin antipruritic and as an anti-infective agent. When ingested.. camphor has a rapid onset of toxic effects.. and camphorated oil is the product most often responsible for its toxicity. The FDA ruled that camphorated oil could not be marketed in the United States and that no product could contain a concentration higher than 11%. It appears in the list of drug products withdrawn or removed from the market for safety or effectiveness.[A254252..L43942] However.. camphor can be found in several nonprescription medications at lower concentrations.[A254252],,Anti-Infective Agents:Anti-Infective Agents.. Local:Antipruritics and Local Anesthetics:Basic Lotions and Liniments:Bicyclic Monoterpenes:Biological Products:Bornanes:Bridged-Ring Compounds:Cardiac Therapy:Complex Mixtures:Ketones:Monoterpenes:Norbornanes:Pharmaceutical Preparations:Plant Extracts:Plant Preparations:Terpenes,,,,[article:A254252:15219304:Love JN.. Sammon M.. Smereck J: Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med. 2004 Jul;27(1):49-54. doi: 10.1016/j.jemermed.2004.02.010.];[link:L43942:Code of Federal Regulations 216.24: Drug products withdrawn or removed from the market for reasons of safety or effectiveness.:https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.24]
DB00003,Dornase alfa,Dornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. The 260-amino acid sequence of dornase alfa is identical to the endogenous human enzyme. Dornase alfa cleaves extracellular DNA to 5-phosphodinucleotide and 5-phosphooligonucleotide end products without affecting intracellular DNA. In individuals with cystic fibrosis.. extracellular DNA.. which is an extremely viscous anion.. is released by degenerating leukocytes that accumulate during inflammatory responses to infections. Enzymatic breakdown of this extracellular DNA appears to reduce sputum viscosity and viscoelasticity.,Adverse reactions occur at a frequency of < 1/1000 and are usually mild and transient in nature. Reported adverse effects include chest pain (pleuritic/non-cardiac).. fever.. dyspepsia.. voice alteration (hoarseness).. pharyngitis.. dyspnea.. laryngitis.. rhinitis.. decreased lung function.. rash.. urticaria.. and conjunctivitis. There is no evidence of carcinogenic or mutagenic properties. The safety of dornase alfa has not been studied in pregnant women.. nursing women and children under the age of 5 years old.,Amino Acids.. Peptides.. and Proteins:Cough and Cold Preparations:Decreased Respiratory Secretion Viscosity:Deoxyribonucleases:Endodeoxyribonucleases:Endonucleases:Enzymes:Enzymes and Coenzymes:Esterases:Expectorants:Hydrolases:Proteins:Recombinant Human Deoxyribonuclease 1,[2184581:Canada:2005-02-22];[2137237:Canada:2004-10-26],>Dornase alfa sequenceLKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRPSQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDRIVVAGMLLRGAVVPDSALPFNFQAAYGLSDQLAQAISDHYPVEVMLK,,[article:A12:8792953:Cramer GW.. Bosso JA: The role of dornase alfa in the treatment of cystic fibrosis. Ann Pharmacother. 1996 Jun;30(6):656-61.];[article:A13:20238314:Jones AP.. Wallis C: Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD001127. doi: 10.1002/14651858.CD001127.pub2.];[article:A14:19255515:Riethmueller J.. Kumpf M.. Borth-Bruhns T.. Brehm W.. Wiskirchen J.. Sieverding L.. Ankele C.. Hofbeck M.. Baden W: Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases. Cell Physiol Biochem. 2009;23(1-3):205-10. doi: 10.1159/000204109. Epub 2009 Feb  18.]
